Patient Opportunity I LMNOX
At closeNov 3, 2026, 8:08 PM EST
Day range unavailable
- YTD
- +10.40%
- 1 year
- +14.09%
- EPS (ttm)
- 3.95
- P/E ratio
- 15.09
- YTD return
- +10.40%
- 1-year return
- +14.09%
- Previous close
- 59.45
- 52-week range
- 48.46 – 64.43
2Y +18.80 (+46.25%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 42.44
- 200-day average
- 38.33
About Patient Opportunity I
The fund normally makes investments that, in the portfolio managers' opinion, offer the opportunity for long-term growth of capital. The portfolio managers exercise a flexible strategy in the selection of investments, not limited by investment style or asset class. It may invest without limit in the common stock of U.S. and foreign issuers of all sizes and in other U.S. and foreign securities. The fund may also borrow money for investment purposes, in amounts up to 10% of the fund's net assets measured as of the time of the borrowing, which is a practice known as leveraging. It is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on LMNOX — it syncs with the Stock Master app.
